<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/788E5CB8-985E-4F9F-AE4B-E2CE86C2DE90"><gtr:id>788E5CB8-985E-4F9F-AE4B-E2CE86C2DE90</gtr:id><gtr:name>Waterford Institute of Technology</gtr:name><gtr:address><gtr:line1>ISOL Research Institute</gtr:line1><gtr:line2>Main Campus</gtr:line2><gtr:line3>Cork Road</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/39F6E0CC-F302-4D7C-8B64-E8E4027CEE09"><gtr:id>39F6E0CC-F302-4D7C-8B64-E8E4027CEE09</gtr:id><gtr:name>Rostock University</gtr:name><gtr:address><gtr:line1>Albert-Einstein-Str.2</gtr:line1><gtr:line4>D-18051 Rostock</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8025D32-2EFA-416A-B79C-BEFA6A379151"><gtr:id>A8025D32-2EFA-416A-B79C-BEFA6A379151</gtr:id><gtr:name>RWTH Aachen University</gtr:name><gtr:address><gtr:line1>Pallwelsstr. 30</gtr:line1><gtr:line4>Aachen</gtr:line4><gtr:line5>D-52056</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1AB2A406-5E61-4163-BCB0-63FF359CE87C"><gtr:id>1AB2A406-5E61-4163-BCB0-63FF359CE87C</gtr:id><gtr:name>MagForce Nanotechnologies AG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8A846018-AC90-44B7-A9F3-3C766E29733E"><gtr:id>8A846018-AC90-44B7-A9F3-3C766E29733E</gtr:id><gtr:name>Oxford Applied Research</gtr:name><gtr:address><gtr:line1>Nanotech House Nursery Road
North Leigh Business Park</gtr:line1><gtr:city>North Leigh</gtr:city><gtr:postCode>OX29 6SN</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2E8E7A84-3BC7-4739-986D-C05FC31789B8"><gtr:id>2E8E7A84-3BC7-4739-986D-C05FC31789B8</gtr:id><gtr:name>Charit? - University of Medicine Berlin</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7DFF6490-A98D-4564-977C-80CDD3868143"><gtr:id>7DFF6490-A98D-4564-977C-80CDD3868143</gtr:id><gtr:name>National Centre for Scientific Research (NCSR) Demokritos</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Physics and Astronomy</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/788E5CB8-985E-4F9F-AE4B-E2CE86C2DE90"><gtr:id>788E5CB8-985E-4F9F-AE4B-E2CE86C2DE90</gtr:id><gtr:name>Waterford Institute of Technology</gtr:name><gtr:address><gtr:line1>ISOL Research Institute</gtr:line1><gtr:line2>Main Campus</gtr:line2><gtr:line3>Cork Road</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/39F6E0CC-F302-4D7C-8B64-E8E4027CEE09"><gtr:id>39F6E0CC-F302-4D7C-8B64-E8E4027CEE09</gtr:id><gtr:name>Rostock University</gtr:name><gtr:address><gtr:line1>Albert-Einstein-Str.2</gtr:line1><gtr:line4>D-18051 Rostock</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8025D32-2EFA-416A-B79C-BEFA6A379151"><gtr:id>A8025D32-2EFA-416A-B79C-BEFA6A379151</gtr:id><gtr:name>RWTH Aachen University</gtr:name><gtr:address><gtr:line1>Pallwelsstr. 30</gtr:line1><gtr:line4>Aachen</gtr:line4><gtr:line5>D-52056</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AB2A406-5E61-4163-BCB0-63FF359CE87C"><gtr:id>1AB2A406-5E61-4163-BCB0-63FF359CE87C</gtr:id><gtr:name>MagForce Nanotechnologies AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A846018-AC90-44B7-A9F3-3C766E29733E"><gtr:id>8A846018-AC90-44B7-A9F3-3C766E29733E</gtr:id><gtr:name>Oxford Applied Research</gtr:name><gtr:address><gtr:line1>Nanotech House Nursery Road
North Leigh Business Park</gtr:line1><gtr:city>North Leigh</gtr:city><gtr:postCode>OX29 6SN</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2E8E7A84-3BC7-4739-986D-C05FC31789B8"><gtr:id>2E8E7A84-3BC7-4739-986D-C05FC31789B8</gtr:id><gtr:name>Charit? - University of Medicine Berlin</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DFF6490-A98D-4564-977C-80CDD3868143"><gtr:id>7DFF6490-A98D-4564-977C-80CDD3868143</gtr:id><gtr:name>National Centre for Scientific Research (NCSR) Demokritos</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1D4E6D35-3EF8-4879-B0D5-C06A2574E2CF"><gtr:id>1D4E6D35-3EF8-4879-B0D5-C06A2574E2CF</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Binns</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800692"><gtr:id>FC659433-BA0A-4067-A7FC-4FBC9A0BCC02</gtr:id><gtr:title>A Novel Method for Producing Functional Nanoparticles for Medical Applications</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800692</gtr:grantReference><gtr:abstractText>An exciting aspect of Nanotechnology is its multidisciplinarity that crosses barriers between physics, chemistry and biology. Recently it has been explored for new cancer therapies, which conventionally use toxic drugs resulting in a balancing act between harming the patient and treating the cancer. A nanotechnology-based approach is to use magnetic nanoparticles less than 10 nanometres across (5,000 times smaller than the width of a human hair) attached to ?targeting molecules? that locate and attach only to cancer cells. Once in place an oscillating external magnetic field heats the particles and their attached cells, thereby killing them, without harming healthy tissue. This gentle treatment is the so-called ?magic bullet? approach and has been shown to work in principle in early clinical trials but is hindered by the available nanoparticles not producing enough heat. In a recent breakthrough at Leicester, the Condensed Matter Physics group in Physics and Astronomy developed a new method of producing suspensions of highly magnetic bio-compatible nanoparticles that will generate 5-10 times as much heat per particle as existing fluids. The grant will support a collaboration between Physics, Chemistry and the Leicester General Hospital to develop the technology, conjugate the nanoparticles with targeting molecules and test the new suspensions for their tumour-killing performance in vitro.</gtr:abstractText><gtr:technicalSummary>There is an intense research effort focused on the application of nanoparticles to medical diagnosis and therapy. The applicant, who is a physicist, specialises in the production and properties of size-selected gas-phase magnetic nanoparticles with diameters in the range 1 - 10nm. Recently, with support from the EPSRC s Life Science Interface (LSI) pogramme, proof-of-principle was demonstrated in a novel method for depositing gas-phase nanoparticles into liquids. This is an important development for medical applications since physical gas-phase methods for producing nanoparticles are by far the most versatile and are able to produce mono-sized particles of virtually any material with good size control. In addition it is possible to prepare complex nanoparticles with core-shell morphologies and alloy constituents, which cannot be produced chemically, for example particles with an FeCo core coated in a Au shell. Now that the technical problem of depositing them into liquids has been solved it is possible to prepare liquid suspensions of nanoparticles with all the above properties and in an environment in which they can be functionalised by attaching biological moieties. These can be targeting molecules, such as nanobodies (targeting paratopes of monoclonal antibodies), peptides or vitamins that locate receptors specific to tumour cells. Thus the particles can be used for targeted image enhancement or targeted treatment through hyperthermia. Further development is needed to enable the source to produce nanoparticle suspensions with good size and volume fraction control. In addition it will be upgraded to be able to produce core-shell particles. By working in a collaboration with the Leicester General Hospital and the Leicester University Chemistry Department, the programme will demonstrate the performance of the functionalised nanoparticles with hyperthermia in vitro. It is envisaged that by the end of the project the source will be close to commercialisation for supply to medical research laboratories.</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>104019</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>46799600-10AF-439A-9E42-FE906CE7B22A</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>E445DF14D6F-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>RWTH Aachen University</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>D38A60EF-26DD-4633-AF92-A1B7B195E3AC</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>8FBDDDDCA2D-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>12B76E16-15F7-497D-9EF8-7039CB1EB8D4</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>136295ABA6C-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Centre for Scientific Research (NCSR) Demokritos</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>D81FEC5D-CA6C-40C9-9304-3963E96925E5</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>9383994E39F-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Waterford Institute of Technology</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>AA848526-611E-4088-AEFD-0ED3B61A4E20</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>44EC2FE98B3-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Research Council</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>40B87057-A706-4FAE-BEE6-612A6B240B9A</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>A4BBC83B5FD-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rostock</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>F7C87FEB-6F3C-464C-BCA4-F598F49191D4</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>018ADE7B672-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Applied Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>AF50D8F9-802C-4FDC-8315-A3DF1D34B0FD</gtr:id><gtr:impact>submission of a 5.3M? proposal to the EC.</gtr:impact><gtr:outcomeId>24C8C04EABD-1</gtr:outcomeId><gtr:partnerContribution>The company has given us free hardware with a value ~&amp;pound;15,000 for the research. The company is also a partner in a new 5.3M? proposal called &amp;quot;Nanotheranostics&amp;quot; submitted to the EC FP7 NMP programme.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating group for the EC proposal</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cancer Studies</gtr:department><gtr:description>Nanotheranostics</gtr:description><gtr:id>926749F7-0A70-42A2-A469-66DA16AD0102</gtr:id><gtr:impact>submission of a 5.3M? proposal to the EC.</gtr:impact><gtr:outcomeId>E7A350192B7-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating group for the proposal, which is based on our novel method for synthesising hogh-performance nanoparticles for medical applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Charit? - University of Medicine Berlin</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Center of Biomedical Nanotechnology (CBN)</gtr:department><gtr:description>Nanotheranostics</gtr:description><gtr:id>D0DD7802-BC8B-4E49-A4C4-52D76E30E8E3</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>81B231AEAB9-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MagForce Nanotechnologies AG</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Nanotheranostics</gtr:description><gtr:id>ABF9DDEB-6B03-4E98-A908-CC6B26B5DA01</gtr:id><gtr:impact>Submission of a 5.3M? FP7 proposal to the EC.</gtr:impact><gtr:outcomeId>DDCD11E8D90-1</gtr:outcomeId><gtr:partnerContribution>The partner had contributed to the case for a new 5.3M? proposal entitled 'Nanotheranostics' submitted to the EC FP7 Nanoscience (NMP) programme to fund the collaboration.</gtr:partnerContribution><gtr:piContribution>We are the co-ordinating insitution for 'Nanotheranostics'.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>EC0EEFB8-7CAE-4220-A7F7-217618CC9684</gtr:id><gtr:impact>I presented a talk on nanotechnology applied to healthcare.

Enthusing school students for science and arousing their in applying nanotechnology to healthcare.</gtr:impact><gtr:outcomeId>EEB36101C8D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B525C8BC-6BC5-461D-ADA0-663B865C1C34</gtr:id><gtr:impact>I presented a talk on nanotechnology applied to healthcare.

Enthusing school students for science and arousing their in applying nanotechnology to healthcare.</gtr:impact><gtr:outcomeId>AC34E68CC32</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>700A072C-EB36-41AB-9987-CD54B03F4258</gtr:id><gtr:impact>I presented a talk on nanotechnology applied to healthcare.

Enthusing school students for science and arousing their in applying nanotechnology to healthcare.</gtr:impact><gtr:outcomeId>778715DF70D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>52C55B29-97EA-4A3B-AE30-3BC0D194D596</gtr:id><gtr:impact>I presented a talk on nanotechnology applied to healthcare.

Enthusing school students for science and arousing their in applying nanotechnology to healthcare.</gtr:impact><gtr:outcomeId>EB2B342C2D5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Nanoparticles with a diameter of ~ 10nm consisting of a metallic ferromagnetic Fe core and a Au shell a few atoms thick. They are expected to have a very high performance for MRI contrast enhancement and tumour hypewrthermia.</gtr:description><gtr:id>23BA68B4-80D7-40F1-938E-FC522EA4DCA4</gtr:id><gtr:impact>New high-performance targeted nanovectors for MRI contrast enhancement and tumour hyperthermia have been developed. The programme did not get as far as in vitro testing but this is the subject of a new application 'Nanotheranostics' submitted to the EC FP7 NMP programme.</gtr:impact><gtr:outcomeId>902E0E3BFA1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>magnetic core-shell nanoparticles</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7DD9A74E-62D6-42A2-976C-0293B9E17F12</gtr:id><gtr:title>A novel approach towards the production of luminescent silicon nanoparticles: sputtering, gas aggregation and co-deposition with H2O</gtr:title><gtr:parentPublicationTitle>The European Physical Journal D</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e73f01c320fa7b2f8b535c1f36d0d9f5"><gtr:id>e73f01c320fa7b2f8b535c1f36d0d9f5</gtr:id><gtr:otherNames>von Haeften K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>6990AF1965A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6DF8B21-8F33-4FF3-8ED6-DF89D04FE2B8</gtr:id><gtr:title>Preparation of hydrosol suspensions of elemental and core-shell nanoparticles by co-deposition with water vapour from the gas-phase in ultra-high vacuum conditions</gtr:title><gtr:parentPublicationTitle>Journal of Nanoparticle Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc87ee85448950ef6c67edbee89bf57c"><gtr:id>bc87ee85448950ef6c67edbee89bf57c</gtr:id><gtr:otherNames>Binns C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>CY6JcafPH8v</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800692</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>